New Medical Device Regulation - Managing the Transition to the New Regulation, Including an Update on Brexit (London, United Kingdom - September 25-26, 2018)

  • ID: 4400790
  • Conference
  • Location: London, United Kingdom
  • 2 Days
  • Management Forum
  • Conference Dates: September 25-26, 2018
1 of 5

This is a period of great change, uncertainty and opportunity within the medical technology and diagnostics sectors. This seminar will help you prepare for these changes and operate successfully in the changed environment in Europe. The seminar will cover in depth the new regulations and how they will be implemented by Member States and Notified Bodies. You will hear the latest thoughts on clinical development, safety monitoring and the implications of Brexit.

This is a seminar you cannot afford to miss as you put in place your strategies for the new environment.

Why you should attend

This seminar will provide key guidance and interpretation of the changes to the regulation and will be of value to all those who are involved with placing a medical device on the market, and anyone who requires an essential overview of the new medical device regulation and its impact on the industry and working practices.

Please note, events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged.

Note: Product cover images may vary from those shown
2 of 5

Programme day one

09.30 Chairman’s welcome and introduction
Dr David Jefferys

09.45 Introduction and background to the new regulation

  • Medical Device Co-ordination Groups
  • Dr David Jefferys

10.45 Discussion

11.00 Refreshments

11.30 Key Preparation for successful implementation

  • Where, what, how?
  • A road map for the new regulation
  • EUDAMED database – maximizing the potential
  • Implications of Brexit
  • John Wilkinson

12.30 Discussion

12.45 Lunch

13.45 Notified Bodies: How the changes will impact NBs and manufacturer’s – including the new rules for IVD conformity assessment

  • Accreditation and designation of NBs
  • How to register with NBs
  • Conformity assessment applications
  • Theresa Jeary

15.00 Discussion

15.10 Refreshments

15.30 Increased vigilance and Post Market Surveillance – how to comply

  • Post Market Surveillance systems appropriate for your device and risk classification
  • Periodic Safety Update Reports (PSURs)
  • Manufacturer’s response times to serious public health threats and deaths caused by devices
  • Dr David Jefferys

16.45 Discussion

17.00 Close of day one

Programme day two

09.00 Welcome to day two
Dr David Jefferys

09.30 Clinical investigations – what is required?

  • Greater protection for patients participating in clinical investigations
  • Products to have an acceptable benefit to risk ratio
  • Product safety and performance
  • Changes in data requirements
  • Restrictions by individual Member States
  • Janette Benaddi

10.30 Discussion

10.45 Refreshments

11.15 IVDs and companion diagnostics

  • Implications and timelines
  • New IVD conformity assessment rules
  • Theresa Jeary

12.30 Discussion

12.45 Lunch

13.45 Other essential considerations

  • Authorised representatives – Increased responsibilities and requirements
  • Single registration numbers for all economic operators
  • New categories
  • Single use devices – Reprocessing?
  • Dr David Jefferys

14.45 Discussion

14.50 Refreshments

15.15 Other essential considerations (continued)

  • Unique device identification
  • Safety and clinical performance summaries
  • Strategies to address the new requirements
  • Dr David Jefferys

16.15 Panel discussion and key take home messages

16.30 Close of forum

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • David Jefferys Mr David Jefferys,
    Senior Vice President ,

    Dr David Jefferys is currently Senior Vice President with Eisai responsible for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia). After qualifying in medicine he worked in clinical and academic medicine, before spending 20 years as a senior regulator for both medicines and medical devices. He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA, joint CEO of MHRA. He was involved in the establishment of the European Medicines Agency, CPMP/CHMP member and MRFG and PER scheme chairman. For the last ten years he has worked in industry and chairs several key committees for ABPI, Efpia and IFPMA. He has lectured and published extensively in drug and device regulation and on benefit risk evaluation.

  • Janette Benaddi Ms Janette Benaddi,
    Director of Clinical & Consulting Europe ,

    Janette Benaddi is the Director of Clinical & Consulting Europe for NAMSA. NAMSA is a global Medical Research Organization offering a breadth of services form preclinical to post market activities throughout the medical device product development cycle.

    She has over 20 years’ experience of managing pre and post market clinical studies in both devices and pharmaceuticals. She has worked with several multinational organizations in various clinical, regulatory and marketing roles. She has extensive experience of conducting clinical studies with medical device products as well as regulatory expertise for CE marking of devices.

    She is a registered nurse, has a BSc in Management studies, a Diploma in Company Direction and a Diploma in Management studies, she holds a teaching certificate and is a Chartered Scientist and Chartered Director. Janette sits on several committees in the device community and industry and has been an instrumental advocate of improving and advancing medical device research in the UK. She has published several articles relating to medical device regulation and clinical studies.

  • Adrian Bartlett Mr Adrian Bartlett,
    Medical Devices EU Policy Manager ,

    Adrian joined the Department of Health in 2008 where he has worked primarily in policy roles, but also on the corporate side. He was previously the policy lead for NHS Reconfiguration, and is currently at the MHRA, leading negotiations on behalf of the UK for the revision to the EU legislation regulating the safety of medical devices and in vitro diagnostic devices. He also worked in the private office of the Permanent Secretary during the 2012 reforms of the Health and Social Care Act, where his portfolio covered social care and public health.

    He has a keen interest in people management; in his spare time he launched a network of professional coaches across the Department of Health, and has recently completed an MSc in Health Policy from Imperial. He is also Chair of a local charity, the Rushey Green Timebank, part of Lewisham Local.

  • Theresa Jeary Ms Theresa Jeary,
    Technical Manager for Medical Devices ,
    Lloyds Register Quality Assurance (LRQA)

    Theresa Jeary holds a Master’s Degree in Pharmaceutical Science and is eligible to be a Pharmaceutical Qualified Person.

    Theresa has over 25 years’ experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments, and has been a part of the team for many commercially available medicinal and medical device products.

    Her first introduction to the Medical device Industry was as the R&D Manager for a medical device manufacturer, with responsibility for the development of several device drug combination products, with the core technology utilizing bovine collagen.

    Having been impressed by the innovative nature and speed of development in the Medical Device Industry, Theresa then pursued a move to the other side of the “fence” and into the Notified Body world of Conformity Assessment. First, at BSI as a Certification Manager in the General Device group, and now with Lloyds Register Quality Assurance (LRQA).

    Over the years, Theresa has conducted many successful consultations with a large number of the European Competent Authorities as well as the European Medicines Agency (EMA) as well as reviewing the classification of borderline products.

    At LRQA, Theresa is the Technical Manager for Medical Devices with responsibility for Devices Drug products and Class III Medical Device Conformity Assessments for a wide range of medical devices including In-Vitro Fertilization Media and Solutions for Organ Preservation.

Note: Product cover images may vary from those shown
5 of 5

Personnel from the following departments:

  • Regulatory affairs
  • Clinical studies
  • Vigilance
  • PMS
  • Quality systems
  • Technical support and business development.
Note: Product cover images may vary from those shown
6 of 5


Rembrandt Hotel
11 Thurloe Pl,
United Kingdom


The Rembrandt Hotel is located at 11 Thurloe Place, London, SW7 2RS. The hotel’s location in central London couldn’t be better, whether you’re travelling for business or leisure. You’ll be right between two of London’s most fashionable areas – South Kensington and Knightsbridge – within walking distance of museums, theatres, Harrods and Hyde Park.

You can hop on the Tube at South Kensington and take the District, Circle or Piccadilly lines direct to the City of London, Heathrow Airport and all other areas of the city. Look out of your window and you may well see the Victoria and Albert Museum – it’s right across the street.

Note: Product cover images may vary from those shown